NCT Number: NCT00390507
Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block II
The purpose of this study is to examine the relationship between post-tetanic count (PTC) and time to first response to Train of four (TOF) stimulation during deep neuromuscular blockade induced by rocuronium.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Dep. of Anesthesia, Rigshospitalet, Copenhagen, Denmark
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- ASA 1-3
- General anaesthesia >1 hour
- Surgery in supine position with possibility of monitoring the neuromuscular blockade at the thumb (n.ulnaris stimulation).
- Written informed content
Exclusion criteria
- Neuromuscular disorders, hepatic and renal dysfunction
- Medication expected to interfere with the neuromuscular blocking agent
- Allergy to any medication used during anaesthesia
- Body weight less or exceeding 20% of the ideal body weight
- Pregnancy or breastfeeding
Treatment and study plan
Primary outcomes
-
Time to first response to TOF stimulation (T1)
Secondary outcomes
-
Time to second response to TOF stimulation (T2)
-
Time to first post-tetanic count (PTC)
-
Number of post-tetanic count at first response to TOF
-
Time to T1=25%
-
Interval 25-75%
-
Time to TOF 0.9
-
Time to TOF 1.0
Sponsors and collaborators
Lead sponsor
Rigshospitalet, Denmark
Other
Registry information
Important dates
- Study start
- 2006
- Primary completion
- 2010
- First posted
- Oct 20, 2006
- Registry last updated
- Sep 6, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
NCT06220136
Anesthesia, General, Neuromuscular Blockade
Ankara, Altındağ, Turkey (Türkiye)
View Trial DetailsEffect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients
NCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsComparison Neuromuscular Blockade Monitors
NCT05006807
Neuromuscular Blockade
Seattle, Washington, United States
View Trial DetailsSafety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
NCT07404579
Neuromuscular Blockade
Zhengzhou, Henan, China
View Trial Details